专题：Potassium and Related Disorders

This cluster of papers focuses on the management of hyperkalemia, particularly in patients with kidney diseases. It covers various aspects such as the use of renin-angiotensin-aldosterone system inhibitors, potassium homeostasis, and the effectiveness of treatments like sodium zirconium cyclosilicate and patiromer. Additionally, it explores the association of hyperkalemia with conditions like chronic kidney disease, heart failure, and gastrointestinal adverse events.
最新文献
Esophageal hematoma in a patient with prior chest radiation therapy and aspirin use

article Full Text OpenAlex

A retrospective analysis of the prevalence of hypophosphatemia and hypocalcemia after intravenous iron polymaltose in the inpatient setting

article Full Text OpenAlex

BRASH syndrome in critical care settings: do we know enough?

article Full Text OpenAlex

The role of serum phosphate and calcium levels in coronary artery calcification progression: A multicenter, longitudinal cohort study

article Full Text OpenAlex

Mycophenolate Mofetil-induced Multiple Ileal Ulcerations in a Renal Transplant Recipient: Diagnostic Challenges and Management

article Full Text OpenAlex

Comparative evaluation of pregnancy-related adverse events associated with proton pump inhibitors using the FDA adverse event reporting system database

article Full Text OpenAlex

Computational structural studies of SGLT2-related polypharmacy

article Full Text OpenAlex

SGLT2 Inhibitors and Complicated Urinary Tract Infections: A Rare Case of Emphysematous Pyelonephritis and Subsequent Recurrence Associated With Dapagliflozin Use

article Full Text OpenAlex

Does Body Mass Index Impact the Outcomes of Peritoneal Dialysis Patients? A Systematic Review and Meta-Analysis of Non-Randomized Trials

review Full Text OpenAlex

Physician‐reported reasons for not prescribing guideline‐directed medical therapy in heart failure with reduced ejection fraction: A prospective registry analysis

article Full Text OpenAlex

近5年高被引文献
SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials

review Full Text OpenAlex 798 FWCI174.38819605

2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure

article Full Text OpenAlex 359 FWCI78.70617698

Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial

article Full Text OpenAlex 254 FWCI55.11637043

Heart Failure Drug Treatment—Inertia, Titration, and Discontinuation

article Full Text OpenAlex 245 FWCI50.55044048

AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review

review Full Text OpenAlex 240 FWCI55.01523885

Diagnosis and Management of Hyponatremia

review Full Text OpenAlex 239 FWCI48.35604418

Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases

review Full Text OpenAlex 234 FWCI49.07605263

Worsening Heart Failure: Nomenclature, Epidemiology, and Future Directions

review Full Text OpenAlex 230 FWCI77.21488229

Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People With Type 2 Diabetes: A Meta-Analysis of Individual Participant Data From Randomized, Controlled Trials

article Full Text OpenAlex 229 FWCI48.02291846

An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors

review Full Text OpenAlex 217 FWCI45.2847696